Cost-effectiveness ratios of biologic treatments varied with pre-loss of exclusivity (LOE) price increase, post-LOE price decrease, and comparator impact, according to a study published in Value in Health.
Cost-effectiveness ratios of biologic treatments varied with pre-loss of exclusivity (LOE) price increase, post-LOE price decrease, and comparator impact, according to a study published in Value in Health.
Cost-effectiveness ratios of...